NCT00139867View on ClinicalTrials.gov

A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2004

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
Parkinson's Disease
Interventions
DRUG

PARCOPA

Trial Locations (1)

Unknown

Schwarz, Milwaukee

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY